Mentice AB (OSTO:MNTC) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:MNTC Mentice AB OSTO:MNTC
71 GF Score
Price kr13.50
GF Value kr26.10
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Mentice AB FFO per Share?

FFO per Share only applies to REITs.

OSTO:MNTC
71GF Score
Mentice AB OSTO:MNTC
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Mentice AB (OSTO:MNTC) Overvalued in 2026?

Based on GuruFocus' analysis, Mentice AB stock appears to be undervalued. The current stock price of kr13.50 is trading 48.3% below its estimated GF Value™ of kr26.10. GuruFocus considers Mentice AB to be Possible Value Trap.

Key valuation signals for OSTO:MNTC:

  • FFO per Share:
  • GF Value™: kr26.10 vs. price of kr13.50 (48.3% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the OSTO:MNTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mentice AB Business Description

Other Exchanges MN2:Germany
Address Odinsgatan 10, Gothenburg, SWE, 411 03
Mentice AB is a provider of software and hardware simulation solutions for image guided interventional therapies, offering proficiency based simulation solutions that help healthcare professionals acquire, retain, and enhance procedural skills, improving productivity and outcomes. Its solutions are scientifically validated and developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are covered. Mentice operates in two segments: Medical Device Industry (MDI), providing end-to-end solutions supporting development and launch of interventional therapies, and Healthcare Systems (HCS). Product areas include Mentice VIST, Physical Sim, Mentice Live, and Ankyras. It operates in EMEA, APAC, and the Americas.
71GF Score

Get the complete analysis for OSTO:MNTC

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr13.50
Price
kr26.10
GF Value